Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Journal of Medical Economics|January 19, 2011
Association between glycemic control and short-term healthcare costs among commercially insured diabetes patients in the United StatesMark Aagren, Wenli LuoJournal of Medical Economics|September 9, 2011
Coverage of insulin delivery devices and basal insulin analogs by US managed care organizationsEdward S Kimball, Mark AagrenExpert Review of Pharmacoeconomics & Outcomes Research|October 4, 2011
Cost-effectiveness of insulin detemir: a systematic reviewDong-Churl Suh, Mark AagrenJournal of Medical Economics|December 5, 2009
Healthcare utilization changes in relation to treatment intensification with insulin aspart in patients with type 2 diabetes. Data from a large US managed-care organizationMark Aagren, Wenli Luo, Elien MoësCurrent Medical Research and Opinion|July 20, 2013
Differences in rates of hypoglycemia and health care costs in patients treated with insulin aspart in pens versus vialsCarl V Asche, Wenli Luo, Mark AagrenJournal of Managed Care Pharmacy : JMCP|January 13, 2012
Cost of self-monitoring of blood glucose in the United States among patients on an insulin regimen for diabetesJason Yeaw, Won Chan Lee, Mark Aagren, et al.Journal of Medical Economics|June 24, 2009
Cost-effectiveness of insulin detemir compared with neutral protamine Hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in five European countriesManuela Helena Gschwend, Mark Aagren, William J ValentineCurrent Medical Research and Opinion|August 1, 2013
Evidence supporting an association between hypoglycemic events and depressionWei Shao, Rabia Ahmad, Naum Khutoryansky, et al.Current Medical Research and Opinion|May 20, 2006
The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countriesStefan Holmstrom, Patricia Buchholz, John Walt, et al.Current Medical Research and Opinion|July 12, 2011
Adherence and persistence to a regimen of basal insulin in a pre-filled pen compared to vial/syringe in insulin-naïve patients with type 2 diabetesErin Buysman, Christopher Conner, Mark Aagren, et al.Pageof 4